Clozapine-Resistant Schizophrenia Treated With Ultra-brief Pulse, Unilateral Electroconvulsive Therapy.
Department of Psychiatry and Mental Health Centro Hospitalar de Lisboa OcidentalLisbon, Portugal Champalimaud Clinical Centre Champalimaud Centre for the Unknown Lisbon, Portugal Department of Psychiatry and Mental Health Centro Hospitalar de Lisboa OcidentalLisbon, Portugal Department of Psychiatry and Mental Health Centro Hospitalar de Lisboa OcidentalLisbon, PortugalChampalimaud Clinical Centre Champalimaud Centre for the Unknown Lisbon, PortugalChampalimaud Research Champalimaud Centre for the Unknown Lisbon, PortugalNOVA Medical School | Faculdade de Ciências Médicas Universidade Nova de Lisboa Lisbon, Portugal Department of Psychiatry and Mental Health Centro Hospitalar de Lisboa OcidentalLisbon, Portugal Champalimaud Clinical Centre Champalimaud Centre for the Unknown Lisbon, Portugal NOVA Medical School | Faculdade de Ciências Médicas Universidade Nova de Lisboa Lisbon, Portugal bernardo.correa@fundacaochampalimaud.pt.
Gonçalo
G
Cotovio
Ana
A
Velosa
Albino J
AJ
Oliveira-Maia
Bernardo
B
Barahona-Correa
D000328:Adult; D014150:Antipsychotic Agents; D003024:Clozapine; D004351:Drug Resistance; D004565:Electroconvulsive Therapy / Q000379:methods*; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D012563:Schizophrenia, Paranoid / Q000188:drug therapy / Q000628:therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003024:Clozapine